St. Jude Medical Inc.
) revealed that it has received the 2014 Innovation Award at
Cardiostim 2014, the 19th World Congress in Cardiac
Electrophysiology and Cardiac Techniques for its Nanostim leadless
pacemaker. Shares of the company edged up 0.3% yesterday following
A congress committee of electrophysiologists has chosen St. Jude
Medical's Nanostim leadless pacemaker for the award being the most
innovative product in electrophysiology and cardiac technique.
Last year, Nanostim pacemaker obtained CE Mark approval in Europe.
After its approval, the pacemaker has been implanted in patients
located in the U.K., Germany, Italy, Czech Republic, France, Spain,
and the Netherlands.
What Is Nanostim Leadless Pacemaker?
The Nanostim leadless pacemaker measures less than 10% of the size
of a conventional pacemaker and can be implanted directly into the
heart by a non-surgical procedure (through femoral vein with a
steerable catheter), unlike conventional pacemakers, which require
a more invasive surgery.
The pacemaker can be placed without the visible surgical pocket,
scar and insulated wires (known as leads) needed for conventional
pacemakers. It can be fully retrieved so that it can be readily
repositioned throughout the implant procedure.
The smaller size and absence of a surgical pocket and a lead make
the pacemaker comfortable for patients, reducing several
complications, including device pocket-related infection and lead
The pacemaker allows patients to live uninhibited lifestyles due to
the elimination of the visible lump and scar at a conventional
pacemaker's implant site, apart from the removal of patient
activity restrictions that may prevent the dislodgement or damage
to a conventional lead.
The device is supported by the St. Jude Medical Merlin Programmer,
which is used to interrogate and program the company's other
pacemakers and implantable cardioverter defibrillators (ICDs). The
device battery is anticipated to have an average lifespan of more
than nine years at 100% pacing, or more than 13 years at 50%
Currently, St. Jude sports a Zacks Rank #2 (Buy). Other stocks in
the medical products industry that are also worth considering
). All of them carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
ST JUDE MEDICAL (STJ): Free Stock Analysis
NEUROMETRIX INC (NURO): Free Stock Analysis
CARDICA INC (CRDC): Free Stock Analysis Report
POSITIVEID CORP (PSID): Get Free Report
To read this article on Zacks.com click here.